Norway· NO-ID_68C88F41-D5CF-4ECD-8836-959B96FF0234
Emcitate
A tiratricol product containing tiratricol, registered in Norway by Rare Thyroid Therapeutics. The same ATC class is registered in 10 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Tiratricol is registered in 10 of 19 countries.
Countries holding a registration under ATC H03AA04 (tiratricol), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 6 of them publish a price we can compare per daily dose
Tiratricol · ATC H03AA04
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
FEST (Norway)- Active substance
- Tiratricol
- Manufacturer
- Rare Thyroid Therapeutics
- Country
- Norway (NO)
- ATC code
- H03AA04
- ATC class
- Tiratricol
- Defined daily dose
- 1.75 mg, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- October 2, 2026
Packs & prices · 2
- no_merkevare_idID_68C88F41-D5CF-4ECD-8836-959B96FF0234
- no_varenummer36773660
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tiratricol in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumEmcitate 350 µgRare Thyroid Therapeutics International
- SpainEMCITATE 350 MICROGRAMOS COMPRIMIDOS DISPERSABLESRare Thyroid Therapeutics International Ab
- FinlandEmcitateRare Thyroid Therapeutics International AB
- IrelandEmcitate 350 microgram dispersible tabletsRare Thyroid Therapeutics International AB
- NetherlandsEmcitate 350 microgram dispergeerbare tablettenRare Thyroid Therapeutics International AB
- PolandEmcitateRare Thyroid Therapeutics International AB
- SwedenEmcitate 350 mikrogram Dispergerbar tablettRare Thyroid Therapeutics International AB
- CzechiaEMCITATERare Thyroid Therapeutics International AB, Stockholm
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Emcitate
- Liechtenstein · Emcitate
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1f7c6266-3c5b-4241-a65e-c08e40814f25 GET /v1/drugs/1f7c6266-3c5b-4241-a65e-c08e40814f25?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Dispergerbar tablett",
"source": "fest",
"status": "A",
"atc_name": "Tiratrikol",
"merkevare_id": "ID_68C88F41-D5CF-4ECD-8836-959B96FF0234",
"name_form_strength": "Emcitate disperg tab 350 mikrog",
"prescription_group": "C"
}See everything about tiratricol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.